Disclosure, stigma of HIV positive child and access to early infant diagnosis in the rural communities of OR Tambo District, South Africa: a qualitative exploration of maternal perspective

BMC Pediatrics

Idowu Anthony Ajayi¹  Daniel Ter Goon⁴  Elza Thomson²  Vincent Oladele Adeniyi³ 

[1] School of Humanities and Social Sciences, University of Fort Hare, East London, South Africa;African Centre for HIV/AIDS Management, Faculty of Economic Management Sciences, University of Stellenbosch, Stellenbosch, South Africa;Adult Wellness/EMTCT Research Project, Cecilia Makiwane Hospital, East London Hospital Complex, Private Bag X 9047, Mdantsane, East London 5200, South Africa;School of Health Sciences, University of Fort Hare, East London, South Africa

关键词: South Africa;    Rural;    Maternal perspectives;    HIV-exposed infants;    Early infant diagnosis;   

Others  :  1224675
DOI  :  10.1186/s12887-015-0414-8

 received in 2015-01-30, accepted in 2015-08-10,  发布年份 2015

【 摘 要 】

Background

Despite the overwhelming evidence confirming the morbidity and mortality benefits of early initiation of highly active anti-retroviral therapy (HAART) in HIV-infected infants, some children are still disadvantaged from gaining access to care. The understanding of the maternal perspective on early infant HIV diagnosis and prompt initiation of HAART has not been adequately explored, especially in the rural communities of South Africa. This study explores the perspectives of mothers of HIV-exposed infants with regard to early infant diagnosis (EID) through a lens of social and structural barriers to accessing primary healthcare in OR Tambo district, Eastern Cape Province, South Africa.

Methods

In this qualitative study, we conducted semi-structured interviews at two primary healthcare centres in the King Sabata Dalindyebo Municipality of the OR Tambo district, South Africa. Twenty-four purposive sample of mothers of HIV-exposed infants took part in the study. Interviews were tape-recorded, transcribed and field notes were obtained. The findings were triangulated with two focus group discussions in order to enrich and validate the qualitative data. Thematic content analysis was employed to analyse the data.

Results

The participants have fairly good knowledge of mother-to-child transmission of HIV and the risks during pregnancy, delivery and breastfeeding. The majority of participants were confident of the protection offered by anti-retroviral drugs provided during pregnancy, however, lack knowledge of optimal time for early infant diagnosis of HIV. Reasons for not accessing EID included fear of finding out that their child is HIV positive, feelings of guilt and/or shame and embarrassment with respect to raising an HIV infected infant. Personal experiences of HIV diagnosis and HAART were associated with participants’ attitudes and beliefs toward care-seeking behaviours. Stigma resulting from their own disclosure to others reduced their likelihood of recommending EID to other members of their communities.

Conclusion

Despite the good knowledge of mothers about infant HIV infection and the availability of treatment, the knowledge of the optimal time for early infant diagnosis is lacking. Fear of infant HIV diagnosis and stigma are challenges for universal coverage of early infant diagnosis in these rural communities. Hence, community education and intensive counselling of pregnant women about early infant diagnosis are urgently needed.

【 授权许可】

   
2015 Adeniyi et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E et al.. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000; 283(9):1175-1182.
• [2]Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD et al.. Maternal viral load, Zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. New Engl J Med. 1996; 335(22):1621-1629.
• [3]World Health Organization. UNAIDS: Global Report: UNAIDS report on the global AIDS epidemic. Geneva: WHO. 2010. Available at:. http://www. unaids.org/globalreport/Global_report.htm webcite
• [4]Newell M-L, Coovadia K, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. The Lancet. 2004; 364(9441):1236-1243.
• [5]Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. P Infect Dis J. 2008;27(9):808.
• [6]Hassan AS, Sakwa EM, Nabwera HM, Taegtmeyer MM, Kimutai RM, Sanders EJ et al.. Dynamics and constraints of early infant diagnosis of HIV infection in rural Kenya. AIDS Behav. 2012; 16(1):5-12.
• [7]Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM et al.. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PloS One. 2012; 7(2):e28510.
• [8]Chiappini E, Galli L, Tovo P-A, Gabiano C, Gattinara GC, Guarino A et al.. Virologic, immunologic and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006; 20(2):207-15.
• [9]Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA et al.. Early antiretroviral therapy and mortality among HIV-infected infants. New Engl J Med. 2008; 359(21):2233-2244.
• [10]Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H et al.. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013; 382(9904):1555-1563.
• [11]Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, Inwani I et al.. Early response to Highly Active Antiretroviral Therapy in HIV-1-infected Kenyan children. J Acquired Immune Def Synd. 2007; 45(3):311-317.
• [12]Bitnum A, Samson L, Chun T-W, Kakkar F, Brophy J, Murray D et al.. Early initiation of antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4 T cells carrying HIV in peripheral blood. Clin Infect Dis. 2014; 59(7):1012-1019.
• [13]World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. 2010. World Health Organization: Geneva. Available at: http://www.who.int/hiv/pub/paediatric/paed_prelim_summary/en/indexhtml [PubMed]. 2010.
• [14]Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquired Immune Def Synd. 2005;38(5):615–7.
• [15]Creek TL, Ntumy R, Seipone K, Smith M, Mogodi M, Smit M, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquired Immune Def Synd. 2007;45(1):102–7.
• [16]National Department of Health. The South African Antiretroviral Treatment Guidelines 2013. Available at:. http://www. kznhealth.gov.za/medicine/2013_art_guidelines.pdf webcite
• [17]Motswere-Chirwa C, Voetsch A, Lu L, Letsholathebe V, Lekone P, Machakaire E, et al. Follow-up of infants diagnosed with HIV-early infant diagnosis program, Francistown, Botswana, 2005–2012. MMWR Morbidity Mortality Weekly Rep. 2014;63(7):158–60.
• [18]Chiduo MG, Mmbando BP, Theilgaard ZP, Bygbjerg IC, Gerstoft J, Lemnge M, et al. Early infant diagnosis of HIV in three regions in Tanzania; successes and challenges. BMC Publ Health. 2013;13(1):910.
• [19]Binagwaho A, Mugwaneza P, Irakoze AA, Nsanzimana S, Agbonyitor M, Nutt CT, et al. Scaling up early infant diagnosis of HIV in Rwanda, 2008–2010. J Public Health Policy. 2013;34(1):2–16.
• [20]Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis. 2007;196(Supplement 3):S474–S81.
• [21]Lilian RR, Kalk E, Technau K-G, Sherman GG. Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of mother-to-child transmission. Paediatr Infect Dis J. 2013;32(10):1080–5.
• [22]Patton JC, Akkers E, Coovadia AH, Meyers TM, Stevens WS, Sherman GG. Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory. Clin Vaccine Immunol. 2007;14(2):201–3.
• [23]Grimwood A, Fatti G, Mothibi E, Eley B, Jackson D. Progress of preventing mother-to-child transmission of HIV at primary healthcare facilities and district hospitals in three South African provinces. SAMJ: South African Medical Journal. 2012;102(2):81–3.
• [24]Rollins N, Little K, Mzolo S, Horwood C, Newell M-L. Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS. 2007;21(10):1341–7.
• [25]Boender TS, Sigaloff KC, Kayiwa J, Musiime V, Calis JC, Hamers RL, et al. Barriers to initiation of pediatric HIV treatment in Uganda: a mixed-method study. AIDS Res Treatment. 2012;2012.
• [26]Babalola S. Readiness for HIV testing among young people in northern Nigeria: the roles of social norm and perceived stigma. AIDS Behav. 2007;11(5):759–69.
• [27]Pettifor A, MacPhail C, Suchindran S, Delany-Moretlwe S. Factors associated with HIV testing among public sector clinic attendees in Johannesburg, South Africa. AIDS Behav. 2010;14(4):913–21.
• [28]Koku EF. Desire for, and uptake of HIV tests by Ghanaian women: the relevance of community level stigma. J Comm Health. 2011;36(2):289–99.
• [29]Wolff B, Nyanzi B, Katongole G, Ssesanga D, Ruberantwari A, Whitworth J. Evaluation of a home-based voluntary counselling and testing intervention in rural Uganda. Health Policy Plan. 2005;20(2):109–16.
• [30]National Health Laboratory Service. Early diagnosis of HIV-infection in infants at 6 weeks of age by province October 2009 Versus October 2010. Report prepared by the National Health Laboratory Service. Run Date: 18/11/2010 13:43:374.
• [31]Woldesenbet S, Goga AE, Jackson DJ for the SA EID study group. The South African Programme to Prevent Mother-to-Child Transmission of HIV (PMTCT): Evaluation of Systems for Early Infant Diagnosis in Primary Health Care Facilities in South Africa: Report on Results of a Situational Assessment, 2010. South African Medical Research Council. Available at:. http://www. nhls.ac.za/assets/files/Situational%20%20assessment%20report%20final_10th%20Oct12.pdf webcite
• [32]Massyn N, Day C, Barron P, Haynes R, English R, Padarath A, editors. District Health Barometer 2011/12. Durban: Health Systems Trust; March 2013. Available at:. http://www. health-e.org.za/wp-content/uploads/2013/04/DHB2011_12lowres.pdf webcite
• [33]Addo VN. Pregnant women's knowledge of and attitudes to HIV testing at Komfo Anokye Teaching Hospital, Kumasi. Ghana Med J. 2006;39(2):50–4.
• [34]Jebessa S, Teka T. Knowledge and attitude towards mother to child transmission of HIV and it's prevention among post natal mothers in Tikur Anbessa and Zewditu Memorial Hospitals, Addis Ababa. Ethiop J Health Dev. 2006;19(3):211–8.
• [35]Callaghan M, Ford N, Schneider H. Review A systematic review of task-shifting for HIV treatment and care in Africa. Hum Resour Health. 2010;8:8–16.
• [36]National Department of Health. The South African antiretroviral treatment guidelines 2010. Available at:. http://apps. who.int/medicinedocs/documents/s19153en/s19153en.pdf webcite
• [37]Nyazulu JCY, Muchiri E, Mazwi S, Ratshefola M. NIMART rollout to primary healthcare facilities increases access toantiretrovirals in Johannesburg: An interrupted time series analysis. SA Med J. 2013;103(4):232–6. doi:10.7196/SAMJ.6380.
• [38]Ngemu E, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Ooyo-Okoth E. Effectiveness of option B highly activeantiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014;7:52.
• [39]Kouanda S, Tougri H, Cissé M, Simporé J, Pietra V, Doulougou B, et al. Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. AIDS Care. 2010;22(7):843–50.
• [40]Lazarus R, Struthers H, Violari A. Starting HIV-positive babies on antiretroviral treatment: Perspectives of mothers in Soweto, South Africa. J Paediatr Health Care. 2010;24(3):176–83.
• [41]Delicio AM, Milanez H, Amaral E, Morais SS, Lajos GJ, e Silva JLCP, et al. Mother-to-child transmission of humanimmunodeficiency virus in aten years period. Reprod Health J. 2011;8:35.
• [42]Townsend CL, Cortina-Borja M, Peckam CS, Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22:973–81.
• [43]Gouveia PAC, Silva GAP, Albuquerque MFPM. Factors associated with mother-to-child transmission of the humanimmunodeficiency virus in Pernanbucho, Brazil 2000–2009. Trop Med Int Health. 2013;18(3):276–85.
• [44]Ngwende S, Gombe NT, Midzi S, Tshimanga M, Shambira G, Chadambuka A. Factors associated with HIV infection amongchildren born to mothers on the prevention of mother to child transmission programme at Chitungwiza Hospital, Zimbabwe, 2008. BMC Publ Health. 2013;13:1181.
• [45]Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town South Africa. Soc Sci Med. 2007;64:1823–31.
• [46]Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57:13–24.
• [47]Ndondoki C, Brou H, Timite-Konan M, Oga M, Amani-Bosse C, Menan H, et al. Universal HIV screening at postnatal points of care: which public health approach for early infant diagnosis in Cote d’Ivoire? PLoS One. 2013;8:e67996.doi:10.1371/journql.pone.0067996.
• [48]Moradmand-Badie B, Moayedi-Nia S, Foroughi M, Dejman M, Nikzad R, Akhlaghkhah M, et al. HIV Positive Patients’Experiences on Receiving an HIV Positive Test: An Iranian–Qualitative Study. Am J Epidemiol Infect Dis. 2014;2(1):47–5.
• [49]Simbayi L, Shisana O, Rehle T, Onoya D, Jooste S, Zungu N, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. Pretoria: Human Sciences Research Council. 2014.